WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NKTR past revenue growth

How has NKTR's revenue growth performed historically?
Company
-2.1%
Industry
151.46%
Market
17.61%
NKTR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NKTR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NKTR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NKTR earnings and revenue history

Current Revenue
$90.1M
Current Earnings
-$276.1M
Current Profit Margin
-306.3%

NKTR Return on Equity

Current Company
-151.6%
Current Industry
-63.5%
Current Market
188%
NKTR's Return on Equity (-151.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NKTR announces earnings.

NKTR Return on Assets

Current Company
-58.2%
Current Industry
2.9%
NKTR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NKTR Return on Capital Employed

Current Company
-72.36%
Current Industry
19.5%
NKTR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NKTR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NKTR$90.12M-$243.11M-$276.06M-40.35%N/A
XBIT$0.00-$22.57M-$24.56M-100.00%N/A
PBYI$235.64M$47.52M$21.59M-1.25%N/A
ACRV$0.00-$59.07M-$60.39MN/AN/A
INO$832.01k-$130.39M-$135.12M-51.33%N/A
View Top Biotech Stocks

NKTR earnings dates

Next earnings date
May 7, 2024

Nektar Therapeutics Earnings & Revenue FAQ

What were NKTR's earnings last quarter?

On Invalid Date, Nektar Therapeutics (NASDAQ: NKTR) reported Q4 2023 earnings per share (EPS) of -$0.22, up 31.25% year over year. Total Nektar Therapeutics earnings for the quarter were -$42.08 million. In the same quarter last year, Nektar Therapeutics's earnings per share (EPS) was -$0.32.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.

What was NKTR's earnings growth in the past year?

As of Q2 2024, Nektar Therapeutics's earnings has grown year over year. Nektar Therapeutics's earnings in the past year totalled -$276.06 million.

What is NKTR's earnings date?

Nektar Therapeutics's earnings date is Invalid Date. Add NKTR to your watchlist to be reminded of NKTR's next earnings announcement.

What was NKTR's revenue last quarter?

On Invalid Date, Nektar Therapeutics (NASDAQ: NKTR) reported Q4 2023 revenue of $23.89 million up 8.45% year over year. In the same quarter last year, Nektar Therapeutics's revenue was $22.02 million.

What was NKTR's revenue growth in the past year?

As of Q2 2024, Nektar Therapeutics's revenue has grown -2.1% year over year. This is 153.56 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Nektar Therapeutics's revenue in the past year totalled $90.12 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.